Pharmamanufacturing.com
In pharma, cancer is king Pharma Manufacturing
WebAccording to McKinsey, “Different sources of health care information will be connected. Innovative companies will make progress in mining the information to gain more nuanced insights to optimize outcome.” How might this strategy play out? In its 2018 report, “New dynamics in the pharmaceutical oncology market,” PwC points to Pfizer’s
Actived: 9 days ago
URL: https://www.pharmamanufacturing.com/sector/large-molecule/article/11298352/in-pharma-cancer-is-king
Gene therapies: On the rise Pharma Manufacturing
WebIn 2017, the FDA approved the first CAR T-cell therapies in the U.S.— Novartis’ Kymriah and Kite/Gilead’s Yescarta, which both treat cancer. Then in December of that year, Spark Therapeutics, a biotech upstart based in Philadelphia, became the first company to ever have a gene therapy for a genetic disease approved by the FDA.
Breaking through pharma's digital innovation barrier
WebAt a time of geopolitical instability, extreme weather disruptions, and sustainability legislation — notably the EU’s Packaging and Packaging Waste Regulations (PPWR) which, if passed, will bring the health care industry in scope of packaging sustainability laws. Flexibility will be needed more than ever in the near future.
Physicians Side with Big Pharma in Biosimilar Name Debate
WebAug. 19, 2014. The ongoing debate over whether biosimilars should be given the same INN as brand-name biologics has divided the healthcare industry. PharmaManufacturing Staff. 10 medical societies and a physicians’ group have sent a letter to the FDA requesting that the agency require biosimilars to have distinct names from brand-name biologics.
U.S. government to invest $75M in new drug ingredient facility
WebThe U.S. government will invest up to $75 million in a new manufacturing facility that will produce ingredients for lipid systems used in novel therapeutic drugs and mRNA vaccines. The new Croda International facility will be located in Lamar, Pennsylvania, and will be funded by both Croda and the government. The British specialty chemicals …
The growing benefits to reshoring pharma operations
WebA clear advantage to the patient — which we are seeing in the current public health crisis — is increased security in access to drugs as drug shortages can be managed close to home. Safety benefits are also likely to increase as local FDA inspections are executed more regularly. While the access to drugs is a clear and important advantage
Evolution in the Era of New Biopharmaceuticals
WebDrug delivery systems pose a different concern for health authorities because many of these systems add an extra layer of complexity regarding product formulation that is difficult to characterize fully. So that no time is wasted in CMC, frequent communication with health authorities will be needed early in the process to ensure that the
Pharma Manufacturing
WebThe new $1.1 billion facility will take up about 40 percent of The Discovery Labs’ 1.6 million square foot biotech and health care campus in King of Prussia, Pa. As part of the major project, The Center for Breakthrough Medicines also plans to hire about 2,000 scientists, lab techs, CGMP manufacturing experts and support staff.
Top Categories
Popular Searched
› Health care at home los robles
› Genesis health club lenexa ks
› Sunshine health doctor search
› Health care social worker education requirements
› Examples of respect in healthcare
› Health claims examples canada
› United healthcare logo vector
› Alliance health card reviews
Recently Searched
› Texas tech masters healthcare administration
› Health care worker bonus requirements
› Ohio retired teacher health insurance
› Carolina family health care patient portal
› Declaration of national health emergency
› Postmenopausal colon health benefits
› Prior authorization health insurance
› Bright health pre authorization list
› Health care management major salary
› Quick and easy healthy dinner recipes for one